205 related articles for article (PubMed ID: 20575190)
1. The baby with the bathwater.
Buyske J
Arch Surg; 2010 Jun; 145(6):577. PubMed ID: 20575190
[No Abstract] [Full Text] [Related]
2. Physician attitudes toward industry: a view across the specialties.
Korenstein D; Keyhani S; Ross JS
Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
[TBL] [Abstract][Full Text] [Related]
3. Physician-industry relations--will fewer gifts make a difference?
Steinbrook R
N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
[No Abstract] [Full Text] [Related]
4. New Swiss guidelines aim to curb big pharma's influence.
Hyde R
Lancet; 2013 Feb; 381(9865):441-2. PubMed ID: 23405415
[No Abstract] [Full Text] [Related]
5. Ethics for the pediatrician: physician interaction with the pharmaceutical industry.
Cicero MX; Curi MB; Mercurio M
Pediatr Rev; 2011 Jan; 32(1):e1-3. PubMed ID: 21196498
[No Abstract] [Full Text] [Related]
6. Conflict of interest: the elephant in your practice.
Kaliski S
Afr J Psychiatry (Johannesbg); 2013 May; 16(3):161, 163, 165. PubMed ID: 23739815
[No Abstract] [Full Text] [Related]
7. Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
Ichikawa I; Clayton EW
Account Res; 2016; 23(4):245-53. PubMed ID: 26829657
[No Abstract] [Full Text] [Related]
8. How to get full, meaningful disclosure.
Moynihan R
Med J Aust; 2011 Nov; 195(10):571. PubMed ID: 22106995
[No Abstract] [Full Text] [Related]
9. Industry relationships with physicians under scrutiny.
Beller GA
J Nucl Cardiol; 2008; 15(6):737-8. PubMed ID: 18984446
[No Abstract] [Full Text] [Related]
10. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
[TBL] [Abstract][Full Text] [Related]
11. Thanks, but no thanks.
Bell H
Minn Med; 2008 Apr; 91(4):26-30. PubMed ID: 18549004
[No Abstract] [Full Text] [Related]
12. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
Fickweiler F; Fickweiler W; Urbach E
BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
[TBL] [Abstract][Full Text] [Related]
13. The ethics of expediency.
Glickel SZ
J Hand Surg Am; 2009; 34(5):799-807. PubMed ID: 19410982
[TBL] [Abstract][Full Text] [Related]
14. Sunshine Has Darkened my Worldview.
Alward WL
Am J Ophthalmol; 2017 Mar; 175():xii-xiii. PubMed ID: 28088286
[No Abstract] [Full Text] [Related]
15. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
16. No more free lunches.
Abbasi K; Smith R
BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
[No Abstract] [Full Text] [Related]
17. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
Steinman MA; Schillinger D
Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
[No Abstract] [Full Text] [Related]
18. Compliance: what you need to know.
Evans GRD; Haeck P; Roth M; McGuire M; Glasberg S; Wells J; Costelloe M; Stokes M; Wargo C
Plast Reconstr Surg; 2011 Nov; 128(5):1143-1148. PubMed ID: 22030493
[No Abstract] [Full Text] [Related]
19. US campaign aims to end industry gifts, speaking fees, and travel for doctors.
Tanne JH
BMJ; 2007 Feb; 334(7590):385. PubMed ID: 17322228
[No Abstract] [Full Text] [Related]
20. Drug representatives: giving you lunch or stealing your soul?
Higgins SP
Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
